Copied
 
 
2023, DKK
01.07.2024
Bruttoresultat

18.066'

Primær drift

-26.430'

Årets resultat

-24.508'

Aktiver

90.106'

Kortfristede aktiver

62.863'

Egenkapital

60.530'

Afkastningsgrad

-29 %

Soliditetsgrad

67 %

Likviditetsgrad

384 %

Resultat
01.07.2024
Årsrapport
2023
01.07.2024
2022
11.07.2023
2021
06.07.2022
2020
22.06.2021
2019
31.07.2020
2018
06.06.2019
2017
29.05.2018
2016
11.05.2017
2015
16.03.2016
Nettoomsætning
Bruttoresultat18.065.785-4.755.562-11.282.020-13.995.469-5.531.190-2.560.5404.465.429300.293-373.916
Resultat af primær drift-26.430.061-37.714.777-26.143.987-28.334.137-15.200.738-8.857.453-906.065-2.506.535-2.347.985
Indtægter af kapitalandele (tilknyttede og associerede) 000000000
Finansielle indtægter1.436.6504.004.059989.01624.24312.84128.89516.6423.608666
Finansieringsomkostninger00-897.643-160.240-63.691-55.919-273.971-56.700-47.706
Andre finansielle omkostninger-2.578.830-1.491.4730000000
Resultat før skat-27.572.241-35.202.191-26.052.614-28.470.134-15.251.588-8.884.477-1.163.394-2.559.627-2.395.025
Resultat-24.507.823-32.719.162-24.239.721-26.264.904-13.554.309-7.014.789-918.364-1.845.857-1.987.381
Forslag til udbytte000000000
Aktiver
01.07.2024
Årsrapport
2023
01.07.2024
2022
11.07.2023
2021
06.07.2022
2020
22.06.2021
2019
31.07.2020
2018
06.06.2019
2017
29.05.2018
2016
11.05.2017
2015
16.03.2016
Kortfristede varebeholdninger16.724.60611.523.6516.074.4864.818.5312.609.3880000
Kortfristede tilgodehavender fra salg og tjenesteydelser 15.028.2005.746.20410.719.2026.507.6182.956.3757.816.4902.947.9107.238.7822.362.048
Likvider31.110.5748.963.64652.967.51214.317.9654.630.7046.681.3402.876.4693.008.413261.631
Kortfristede aktiver62.863.38026.233.50100014.497.8305.824.37910.247.1952.623.679
Immaterielle aktiver og goodwill24.697.14711.286.4940000000
Finansielle anlægsaktiver857.642749.337575.742575.742702.88960.69626.30279.53462.592
Materielle aktiver1.688.2871.643.39138.62880.033121.18532.71241.29197.629154.122
Langfristede aktiver27.243.07613.679.222614.370655.775824.07493.40867.593177.163216.714
Aktiver90.106.45639.912.72370.375.57026.299.88911.020.54114.591.2385.891.97210.424.3582.840.393
Aktiver
01.07.2024
Passiver
01.07.2024
Årsrapport
2023
01.07.2024
2022
11.07.2023
2021
06.07.2022
2020
22.06.2021
2019
31.07.2020
2018
06.06.2019
2017
29.05.2018
2016
11.05.2017
2015
16.03.2016
Forslag til udbytte000000000
Egenkapital60.530.07315.487.30648.206.4686.551.1279.269.45112.597.8663.760.9114.679.2751.910.984
Hensatte forpligtelser0000089.400660.9151.389.0830
Langfristet gæld til banker000000000
Anden langfristet gæld015.684.63516.360.493397.0730000
Leverandører af varer og tjenesteydelser3.343.8401.578.5182.546.7161.924.101397.601644.333305.824463.918140.877
Kortfristede forpligtelser16.358.5206.991.3046.484.4673.388.2691.354.0171.675.7841.151.0673.856.000429.409
Gældsforpligtelser29.576.38324.425.41722.169.10219.748.7621.751.0901.903.9721.470.1464.356.000929.409
Forpligtelser29.576.38324.425.41722.169.10219.748.7621.751.0901.903.9721.470.1464.356.000929.409
Passiver90.106.45639.912.72370.375.57026.299.88911.020.54114.591.2385.891.97210.424.3582.840.393
Passiver
01.07.2024
Nøgletal
01.07.2024
Årsrapport
2023
01.07.2024
2022
11.07.2023
2021
06.07.2022
2020
22.06.2021
2019
31.07.2020
2018
06.06.2019
2017
29.05.2018
2016
11.05.2017
2015
16.03.2016
Afkastningsgrad -29,3 %-94,5 %-37,1 %-107,7 %-137,9 %-60,7 %-15,4 %-24,0 %-82,7 %
Dækningsgrad Na.Na.Na.Na.Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.Na.Na.Na.Na.
Egenkapitals-forretning -40,5 %-211,3 %-50,3 %-400,9 %-146,2 %-55,7 %-24,4 %-39,4 %-104,0 %
Payout-ratio Na.Na.Na.Na.Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal Na.Na.-2.912,5 %-17.682,3 %-23.866,4 %-15.839,8 %-330,7 %-4.420,7 %-4.921,8 %
Soliditestgrad 67,2 %38,8 %68,5 %24,9 %84,1 %86,3 %63,8 %44,9 %67,3 %
Likviditetsgrad 384,3 %375,2 %Na.Na.Na.865,1 %506,0 %265,7 %611,0 %
Resultat
01.07.2024
Gæld
01.07.2024
Årsrapport
01.07.2024
Nyeste:01.01.2023- 31.12.2023(offentliggjort: 01.07.2024)
Information om virksomhedens regnskabsklasse:This annual report has been presented in accordance with the provisions of the Danish Financial Statements Act governing reporting class B enterprises with addition of a few provisions for reporting class C.
Oplysning om eventualaktiver:13 Contingent assetsThe company has a deferred tax asset that amounts to DKK 20,071 thousand which has not been capitalized due to the uncertainty of when the company is able to use it.
Beretning
01.07.2024
Dato for ledelsens godkendelse af årsrapporten:2024-06-19
Beskrivelse af usikkerhed ved indregning eller måling:Uncertainty relating to recognition and measurementAs the Company is a development company, there is a natural uncertainty associated with the measurement of the Company’s development activities and future earnings. At 31 December 2023, the Company has recognised DKK 9,991 thousand regarding ongoing development projects and DKK 14,706 thousand regarding completed developments projects. The value of the development projects depends on the Company’s ability to develop, market and attracting enough customers, who through the sale of the systemes generate positive earnings that could yield the total investment. Accordingly, Management has deemed the valuation sound. If the Company’s sales and growth deviate significantly from the current plans, there may be uncertainty associated with the valuation.
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:The Board of Directors and the Executive Board have today considered and approved the annual report of Norlase ApS for the financial year 01. 01. 2023 - 31. 12. 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Primary activitiesThe Company's principal activity is the commercialization of high-tech medical products and services based on laser technology, along with any related activities the Board deems appropriate. This year’s results show a gross profit of DKK 18,066 thousand, compared to a gross loss of DKK 4,442 thousand the previous year. This marks the first full year of gross profitability for the Company. The net result is a loss of DKK 24,508 thousand, compared to a net loss of DKK 32,719 thousand the year before. Management considers this performance in line with expectations, given that the Company is still in the early growth phase, requiring significant expansion and development activities. Equity stands at DKK 60,530 thousand as of the balance sheet date. Key activities during the year included continuing to grow the adoption of the Company's existing products and launching its newest product, the ECHO pattern scanning laser photocoagulator. The results showed significant growth in sales compared to the previous year, which was in line with expectations. The Company continued to invest heavily in the development of new products and technologies, as well as in further development of existing products. Based on these efforts, the Company expects to launch another innovative product in 2024. During the financial year, the Company successfully raised equity financing of DKK 69. 5 million. This financing provides the necessary resources to pursue future development and support the Company's growth strategy, although further funding may be considered to support expansion during this scale-up phase. Based on these developments, Management assesses that the Company is in a solid economic position.